{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,5]],"date-time":"2022-04-05T20:22:32Z","timestamp":1649190152297},"reference-count":15,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2004,4,1]],"date-time":"2004-04-01T00:00:00Z","timestamp":1080777600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2004,4]]},"DOI":"10.1016\/j.ijantimicag.2003.08.012","type":"journal-article","created":{"date-parts":[[2004,3,17]],"date-time":"2004-03-17T10:36:34Z","timestamp":1079519794000},"page":"394-397","source":"Crossref","is-referenced-by-count":2,"title":["Is the MIC useful in deciding to treat endocarditis surgically?"],"prefix":"10.1016","volume":"23","author":[{"given":"B.I","family":"Walton","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.M","family":"Wallace","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N","family":"Kukreja","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R","family":"Kharbanda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E","family":"Varey-Tyburczy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.P.R","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.H","family":"Swanton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2003.08.012_BIB1","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1093\/eurheartj\/16.suppl_B.80","article-title":"Medical treatment of staphylococcal infective endocarditis","volume":"16","author":"Bille","year":"1995","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ijantimicag.2003.08.012_BIB2","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1001\/archinte.155.15.1641","article-title":"Clinical features, site of involvement, bacteriologic findings, and outcome of infective endocarditis in intravenous drug users","volume":"155","author":"Mathew","year":"1995","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.ijantimicag.2003.08.012_BIB3","unstructured":"Stokes E, Ridgway G. Clinical microbiology. 6th ed. London: Edward Arnold; 1987."},{"key":"10.1016\/j.ijantimicag.2003.08.012_BIB4","doi-asserted-by":"crossref","unstructured":"Antibiotic treatment of streptococcal, enterococcal, and staphylococcal endocarditis. Working Party of the British Society for Antimicrobial Chemotherapy. Heart 1998;79:207\u201310.","DOI":"10.1136\/hrt.79.2.207"},{"key":"10.1016\/j.ijantimicag.2003.08.012_BIB5","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1001\/jama.274.21.1706","article-title":"Antibiotic treatment of adults with infective endocarditis due to streptococci, enterococci, staphylococci, and HACEK microorganisms. American Heart Association","volume":"274","author":"Wilson","year":"1995","journal-title":"JAMA"},{"key":"10.1016\/j.ijantimicag.2003.08.012_BIB6","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1136\/hrt.77.3.191","article-title":"Infective endocarditis: some popular tenets debunked?","volume":"77","author":"Eykyn","year":"1997","journal-title":"Heart"},{"key":"10.1016\/j.ijantimicag.2003.08.012_BIB7","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1093\/jac\/48.2.322","article-title":"BSAC standardized disc susceptibility testing method","volume":"48","author":"Andrews","year":"2001","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2003.08.012_BIB8","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1136\/heart.88.1.53","article-title":"Mortality from infective endocarditis: clinical predictors of outcome","volume":"88","author":"Wallace","year":"2002","journal-title":"Heart"},{"key":"10.1016\/j.ijantimicag.2003.08.012_BIB9","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/0002-9343(94)90143-0","article-title":"New criteria for diagnosis of infective endocarditis: utilization of specific echocardiographic findings. Duke Endocarditis Service","volume":"96","author":"Durack","year":"1994","journal-title":"Am J Med"},{"key":"10.1016\/j.ijantimicag.2003.08.012_BIB10","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1136\/hrt.59.1.62","article-title":"Infective endocarditis: incidence and mortality in the North East Thames Region","volume":"59","author":"Skehan","year":"1988","journal-title":"Br Heart J"},{"key":"10.1016\/j.ijantimicag.2003.08.012_BIB11","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1093\/jac\/38.3.507","article-title":"Treatment of endocarditis with teicoplanin: a retrospective analysis of 104 cases","volume":"38","author":"Wilson","year":"1996","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2003.08.012_BIB12","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1086\/367661","article-title":"Combination antibiotic therapy for infective endocarditis","volume":"36","author":"Le","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2003.08.012_BIB13","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1086\/323785","article-title":"Long-term outcome of infective endocarditis: the impact of early surgical intervention","volume":"33","author":"Bishara","year":"2001","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2003.08.012_BIB14","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1001\/jama.202.3.199","article-title":"Studies on the bacteremia of bacterial endocarditis","volume":"202","author":"Werner","year":"1967","journal-title":"JAMA"},{"key":"10.1016\/j.ijantimicag.2003.08.012_BIB15","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1093\/jac\/48.suppl_1.17","article-title":"Establishing MIC breakpoints and the interpretation of in vitro susceptibility tests","volume":"48","author":"MacGowan","year":"2001","journal-title":"J Antimicrob Chemother"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857903004369?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857903004369?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,2,14]],"date-time":"2019-02-14T16:50:26Z","timestamp":1550163026000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857903004369"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,4]]},"references-count":15,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2004,4]]}},"alternative-id":["S0924857903004369"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2003.08.012","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2004,4]]}}}